An interventional study of Auriculotherapy for analgesic use and Placebo auriculotherapy in Musculoskeletal Pain and Breast Cancer, sponsored by Centre Francois Baclesse. Completed at 7 sites in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-12.
Sponsored by Centre Francois Baclesse · Not applicable, Interventional, and Supportive care
Auriculotherapy is a complementary medicine, with few side effects, without contraindication, inexpensive and not very restrictive.Its efficacy has been found in several tests especially for the treatment of intraoperative pain. It remains more controversial in other indications. Evaluation of the value of auriculotherapy is often difficult because of the methodological limitations of the trials conducted. In the daily practice, the auriculotherapy is proposed to improve the articular pains of patients treated by AA. This Phase III study aims at validate this approach.
493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.
This study's enrollment of 197 is above the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.
Browse Musculoskeletal Pain studies →Centre Francois Baclesse is the lead sponsor of 109 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Auriculotherapy for analgesic use
Device: Auriculotherapy for analgesic use
Placebo auriculotherapy
Device: Placebo auriculotherapy
The ASP will be applied to specific pain points
The ASP will be applied to placebo points (not specific to pain)
Decrease in the overall pain score
The proportion of patients with a 2-point or greater decrease in the overall pain
Time frame: 3 months after auriculotherapy initiation
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Francois Baclesse